ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 612 out of 3647

$340K Total Retail Price of All Prescriptions

Rank: 1786 out of 3647

602 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 11,617 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$27 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 648 613 1 2
SIMVASTATIN 634 609 2 1
LEVOXYL 539 508 3 125
OMEPRAZOLE 476 446 4 3
LOVASTATIN 431 421 5 21
LISINOPRIL 416 409 6 4
ATENOLOL 385 355 7 10
ATORVASTATIN CALCIUM 310 292 8 13
METOPROLOL TARTRATE 295 258 9 7
ENALAPRIL MALEATE 274 265 10 35
HYDROCHLOROTHIAZIDE 272 244 11 9
BENAZEPRIL HCL 228 228 12 71
FUROSEMIDE 226 213 13 8
LOSARTAN POTASSIUM 225 198 14 11
TRIAMTERENE-HCTZ 225 217 14 58
WARFARIN SODIUM 216 213 16 15
DILTIAZEM 24HR CD 206 202 17 155
METFORMIN HCL 198 173 18 6
K-TAB 197 150 19 319
ALENDRONATE SODIUM 168 168 20 23
PRAVASTATIN SODIUM 156 145 21 16
SPIRIVA 152 139 22 93
HYDROCODONE-ACETAMINOPHEN 144 120 S3 23 12
SERTRALINE HCL 144 136 23 27
RANITIDINE HCL 138 125 25 29
PAROXETINE HCL 135 123 26 60
METFORMIN HCL ER 132 121 27 92
ALLOPURINOL 131 120 28 37
GLYBURIDE 131 129 R 28 54
TRAMADOL HCL 129 129 30 22
TRAZODONE HCL 123 102 31 64
NITROGLYCERIN PATCH 113 113 32 203
TRIAMTERENE-HYDROCHLOROTHIAZID 107 107 33 223
VENTOLIN HFA 99 94 34 88
NIFEDIPINE ER 99 76 34 67
FLUTICASONE PROPIONATE 96 85 36 32
GABAPENTIN 93 81 37 17
FOSINOPRIL SODIUM 91 87 38 241
CRESTOR 91 75 38 19
TERAZOSIN HCL 88 88 40 103
DIOVAN 84 84 41 40
KLOR-CON 8 83 83 42 264
LANOXIN 83 83 42 231
CLONIDINE HCL 75 71 44 46
VERAPAMIL ER 69 60 45 99
TRICOR 69 62 45 144
TAMSULOSIN HCL 64 52 47 28
ISOSORBIDE MONONITRATE ER 61 61 48 56
DOXAZOSIN MESYLATE 60 49 49 57
OXYBUTYNIN CHLORIDE 58 58 50 107
FLUOXETINE HCL 56 40 51 68
PANTOPRAZOLE SODIUM 56 52 51 38
GEMFIBROZIL 55 44 53 82
DONEPEZIL HCL 54 54 54 30
LANSOPRAZOLE 54 52 54 116
MICARDIS 54 44 54 309
GLIMEPIRIDE 54 54 54 45
CYCLOBENZAPRINE HCL 52 39 R 58 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.